keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
May 17 - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Formats
Topics
May 17 - PST/PDT (Pacific Daylight, GMT-7)
search
Formats
Topics
08:00 - 08:055 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Welcoming Remarks
- Patrick Murphy - Digital Events Conference Producer, Informa Connect, UK
08:05 - 08:3530 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Evaluation of multi-cancer early detection technology
- Hadly Clark - Associate Director, FasterCures, a Centre of the Milken Institute, USA
08:35 - 09:0530 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Invest to stop invasiveness during ovarian cancer diagnosis
- Oriana Papin-Zoghbi - CEO and Co-founder, AOADX, USA
09:05 - 10:0560 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Discussion on the future of cancer diagnostics. What role will liquid biopsies play?
- Alessandra Cesano - Chief Medical Officer, ESSA Pharmaceuticals, USA
- Tom Miller - Founding & Managing Partner, GreyBird Ventures, LLC, USA
- Hadly Clark - Associate Director, FasterCures, a Centre of the Milken Institute, USA
10:05 - 10:3025 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Break & Networking
10:30 - 11:3060 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Discussion with the pros of next-generation sequencing. Is precision medicine the way forward?
- Anton Buzdin - Chief Scientific Officer, OncoBox, USA
11:30 - 12:0030 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Conversation with big pharma; get on board with precision medicine investments
- Gabriele Allegri - Global Commercial Head - Precision Medicine, The Janssen Pharmaceutical Companies of Johnson & Johnson, USA
12:00 - 12:3030 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
How to adapt your R&D and clinical strategies to maximise partnership opportunity
- Jeffrey M. Bockman - Executive Vice President, BioConsulting and Head of Oncology, Lumanity, USA
12:30 - 13:0030 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Break & Networking
13:00 - 13:3030 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Invest to improve breast cancer chemotherapy treatment
- Bob Linke - CEO, Osmol Therapeutics, USA
13:30 - 14:0030 mins
Day 1 - Therapeutic Area Partnerships Oncology 2023
Partner with the digital clinic revolutionising cancer survivor patient cancer
- Hil Moss - Co-Founder/Chief Executive Officer, VivorCare, USA
Filter
Formats
Topics